New pill formulation for brain conditions tested in healthy volunteers
Knowledge-focused
Completed
This study compared a new soft-gel capsule version of NPT 2042 to the original in 8 healthy adults. The goal was to measure how the drug is absorbed and processed by the body. The results will help guide future dosing for conditions like epilepsy and Alzheimer's disease.
Phase: PHASE1 • Sponsor: NeuroPro Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:29 UTC